Table 2.
Efficacy | Control group | Study group | χ2 | P |
---|---|---|---|---|
CR | 0 | 0 | ||
PR | 21 (55.3%) | 17 (56.7%) | ||
SD | 12 (31.6%) | 13 (43.3%) | ||
PD | 5 (13.2%) | 0 (0.0%) | ||
ORR | 21 (55.3%) | 17 (56.7%) | 0.013 | 0.908 |
DCR | 33 (86.8%) | 30 (100%) | 2.548 | 0.11 |
mPFS(m) | 9.6(95%CI: 7.92-11.28) | 12.7(95%CI:11.34-14.00) |